Clinical Trial Update: Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HMPL-760 plus R-GemOx versus placebo plus R-GemOx in relapsed/refractory diffuse large B-cell lymphoma; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• HMPL-760
• OXALIPLATIN (Oxaliplatin)
• R-GemOx (rituximab, gemcitabine, oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: Hutchmed | Conditions: Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING